Amanote Research
Register
Sign In
Essential Thrombocythemia
New England Journal of Medicine
- United States
doi 10.1056/nejmc1917586
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
March 19, 2020
Authors
Unknown
Publisher
Massachusetts Medical Society
Related search
Essential Thrombocythemia
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Myelofibrotic Transformation in Essential Thrombocythemia. Author Reply
Haematologica
Hematology
ASXL1 Mutations in Chinese Patients With Essential Thrombocythemia
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Recent Advances in Understanding Myelofibrosis and Essential Thrombocythemia
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Hydroxyurea Compared With Anagrelide in High-Risk Essential Thrombocythemia
New England Journal of Medicine
Medicine
Advances and Challenges in the Management of Essential Thrombocythemia
Therapeutic Advances in Hematology
Hematology
Updates in the Management of Polycythemia Vera and Essential Thrombocythemia
Therapeutic Advances in Hematology
Hematology
Serum Erythropoietin Levels in Essential Thrombocythemia: Phenotypic and Prognostic Correlates
Blood Cancer Journal
Oncology
Hematology
Elevated Procoagulant Microparticles Expressing Endothelial and Platelet Markers in Essential Thrombocythemia
Haematologica
Hematology